DR.AGARWALS EYE HOSPITAL LTD.-$

Company Profile

DR.AGARWALS EYE HOSPITAL LTD.-$ had its IPO on under the ticker symbol DRAGARWQ.

The company operates in the sector and industry. DR.AGARWALS EYE HOSPITAL LTD.-$ has a staff strength of 0 employees.

Stock update

Shares of DR.AGARWALS EYE HOSPITAL LTD.-$ opened at ₹2453.65 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹2263 - ₹2488.95, and closed at ₹2297.2.

This is a -6.38% slip from the previous day's closing price.

A total volume of 6,576 shares were traded at the close of the day’s session.

In the last one week, shares of DR.AGARWALS EYE HOSPITAL LTD.-$ have slipped by -7.54%.

DR.AGARWALS EYE HOSPITAL LTD.-$'s Key Ratios

DR.AGARWALS EYE HOSPITAL LTD.-$ has a market cap of ₹10.57 billion, indicating a price to book ratio of 6.1609 and a price to sales ratio of 2.3598.

In the last 12-months DR.AGARWALS EYE HOSPITAL LTD.-$’s revenue was ₹0 with a gross profit of ₹1.16 billion and an EBITDA of ₹0. The EBITDA ratio measures DR.AGARWALS EYE HOSPITAL LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, DR.AGARWALS EYE HOSPITAL LTD.-$’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, DR.AGARWALS EYE HOSPITAL LTD.-$’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

DR.AGARWALS EYE HOSPITAL LTD.-$’s PE and PEG Ratio

Forward PE

0

Trailing PE

842.6966

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DR.AGARWALS EYE HOSPITAL LTD.-$’s profitability.

DR.AGARWALS EYE HOSPITAL LTD.-$ stock is trading at a EV to sales ratio of 3.0843 and a EV to EBITDA ratio of 10.4278. Its price to sales ratio in the trailing 12-months stood at 2.3598.

DR.AGARWALS EYE HOSPITAL LTD.-$ stock pays annual dividends of ₹1.5 per share, indicating a yield of 0.08% and a payout ratio of 5.49%.

Balance sheet and cash flow metrics

Total Assets

₹3.90 billion

Total Liabilities

₹550.80 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

5.49%

DR.AGARWALS EYE HOSPITAL LTD.-$ ended 2024 with ₹3.90 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹3.90 billion while shareholder equity stood at ₹1.13 billion.

DR.AGARWALS EYE HOSPITAL LTD.-$ ended 2024 with ₹0 in deferred long-term liabilities, ₹550.80 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹1.80 million in goodwill. Its cash balance stood at ₹273.80 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹357.70 million.

DR.AGARWALS EYE HOSPITAL LTD.-$’s total current assets stands at ₹465.40 million while long-term investments were ₹0 and short-term investments were ₹28.30 million. Its net receivables were ₹101.10 million compared to accounts payable of ₹266.90 million and inventory worth ₹60.00 million.

In 2024, DR.AGARWALS EYE HOSPITAL LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, DR.AGARWALS EYE HOSPITAL LTD.-$ paid ₹0.05 in dividends in 2024.

Other key metrics

Current Trading Price

₹2297.2

52-Week High

₹2340

52-Week Low

₹732.8365

Analyst Target Price

₹

DR.AGARWALS EYE HOSPITAL LTD.-$ stock is currently trading at ₹2297.2 per share. It touched a 52-week high of ₹2340 and a 52-week low of ₹2340. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1845.69 and 200-day moving average was ₹1355.1 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.